title: Therapeutic application of matrix biology.
authors.affiliation: Telios Pharmaceuticals, Inc., San Diego, California 92121, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Tschopp
authors.forename: W S
authors.initials: WS
authors.lastname: Craig
authors.forename: J
authors.initials: J
authors.lastname: Tolley
authors.forename: J
authors.initials: J
authors.lastname: Blevitt
authors.forename: C
authors.initials: C
authors.lastname: Mazur
authors.forename: M D
authors.initials: MD
authors.lastname: Pierschbacher
mesh_terms: D000595:Amino Acid Sequence; D023181:Antimicrobial Cationic Peptides; D001672:Biocompatible Materials; D002448:Cell Adhesion; D005109:Extracellular Matrix / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000737:chemistry; D010455:Peptides / Q000737:chemistry; D010456:Peptides, Cyclic / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D019736:Prostheses and Implants; D014407:Tumor Cells, Cultured
chemical_list: D023181:Antimicrobial Cationic Peptides; D001672:Biocompatible Materials; D009842:Oligopeptides; D010455:Peptides; D010456:Peptides, Cyclic; C076536:Peptite 2000; C047981:arginyl-glycyl-aspartic acid; C085362:TP 9201; D005340:Fibrinogen